Upstream of FAM111B, a combination of metformin and aspirin has been demonstrated to markedly reduce FAM111B levels in pancreatic cancer cells, with “cholesterol biosynthesis,” “G1/S checkpoint regulation,” and “axon guidance” signaling pathways exhibiting significant enrichment [23]. Here, FAM111B is linked to familial pancreatic carcinoma.